ID
43829
Description
IRESSA™ (Gefitinib) in Breast Cancer Patients; ODM derived from: https://clinicaltrials.gov/show/NCT00632723
Link
https://clinicaltrials.gov/show/NCT00632723
Keywords
Versions (3)
- 5/5/16 5/5/16 -
- 6/18/16 6/18/16 -
- 9/20/21 9/20/21 -
Uploaded on
September 20, 2021
DOI
To request one please log in.
License
Creative Commons BY 4.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Eligibility Breast Cancer NCT00632723
Eligibility Breast Cancer NCT00632723
- StudyEvent: Eligibility
Description
Exclusion Criteria
Alias
- UMLS CUI
- C0680251
Description
previous chemotherapy regimens
Data type
boolean
Alias
- UMLS CUI [1,1]
- C0205156
- UMLS CUI [1,2]
- C0392920
Description
prior anthracycline chemotherapy
Data type
boolean
Alias
- UMLS CUI [1]
- C0003234
Description
radiotherapy completed
Data type
boolean
Alias
- UMLS CUI [1]
- C1522449
Description
incomplete healing from prior surgery
Data type
boolean
Alias
- UMLS CUI [1]
- C0543478
Description
neurological symptoms with spinal cord compression
Data type
boolean
Alias
- UMLS CUI [1,1]
- C0235031
- UMLS CUI [1,2]
- C0037926
Description
active interstitial lung disease
Data type
boolean
Alias
- UMLS CUI [1]
- C0206062
Similar models
Eligibility Breast Cancer NCT00632723
- StudyEvent: Eligibility
C0677930 (UMLS CUI [1,2])
C0749192 (UMLS CUI [2])
C0039286 (UMLS CUI [1,2])
C2584629 (UMLS CUI [2])
C0392920 (UMLS CUI [1,2])
C0037926 (UMLS CUI [1,2])